Skip to main content
| Hans-Günter Meyer-Thompson | International

EMCDDA. What are the lessons to be learnt from the European Drug Report 2022? 

EMCDDA. What are the lessons to be learnt from the European Drug Report 2022? 

(…) For me, the take-home message that stands out from our analysis of drug trends in 2022 can be summarised as ‘Everywhere, Everything, Everyone’. Today, we face a situation where we can observe the impact of drug problems almost everywhere. Within the European Union, drug problems complicate other important issues such as homelessness, the management of psychiatric disorders and reducing youth criminality. We are also observing greater levels of violence and corruption driven by the drug market in some countries. Internationally, events also have the potential to impact on the drug problems we see in Europe. In this report, we consider how developments in Afghanistan could change drug flows in ways that may have important future implications, and how the humanitarian crisis arising from the war on Ukraine could create new challenges for European drug services. (EMCDDA, Lissabon, 14.06.2022, 14.06.2022 (Message from the Director 2/2022))

https://www.emcdda.europa.eu/news/2022/2/lessons-to-be-learnt-european-drug-report-2022_en